CNBC Cures: Ultragenyx CEO Emil Kakkis on rare disease bootcamp, road to profitability

Emil Kakkis, Ultragenyx president and CEO, joins 'Squawk Box' to discuss the company's bootcamp for the rare disease fight, road to profitability, and more.